Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Interferon beta-1b-induced Sweet's syndrome in a patient with multiple sclerosis.
Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-beta1b.
SigmaPharm Laboratories Products
Role of regulatory b cells in neuroimmunologic disorders.
Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide.
Spectrum of nontraumatic myelopathies in Ethiopian patients: hospital-based retrospective study.
Gpr126 functions in Schwann cells to control differentiation and myelination via G-protein activation.
The challenge of comorbidity in clinical trials for multiple sclerosis.
Glatiramer acetate (GA) prevents TNF-α-induced monocyte adhesion to primary endothelial cells through interfering with the NF-κB pathway.
Identical lesion morphology in primary progressive and relapsing-remitting MS -an ultrahigh field MRI study.
Biomarkers for Brain Disorders: Challenges and Opportunities
Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience.
Dimethylfumarate protects against TNF-α-induced secretion of inflammatory cytokines in human endothelial cells.
In vivo time-lapse imaging shows dynamic oligodendrocyte progenitor behavior during zebrafish development.
Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results.
Primary infection with the Epstein-Barr virus and risk of multiple sclerosis.
A randomized controlled phase II trial of riluzole in early multiple sclerosis.
Boxed warning of HBV risk added to Rituxan, Arezerra
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.
Multifocal Tumefactive Demyelination Mimicking Intracranial Neoplasm.
Biologics-induced autoimmune diseases.
A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis.
Regenerative cellular therapies for neurologic diseases.
Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies.
Nanoparticle transport across the blood brain barrier.

Pages